WallStreetZenWallStreetZen

NASDAQ: ZEAL
Zealand Pharma A Earnings & Revenue

Open Broker Account

ZEAL past revenue growth

How has ZEAL's revenue growth performed historically?
Company
-23.47%
Industry
1,129.09%
Market
119.04%
ZEAL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ZEAL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ZEAL's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ZEAL earnings and revenue history

Current Revenue
$44.3M
Current Earnings
-$154.3M
Current Profit Margin
-348%

ZEAL Return on Equity

Current Company
-94.4%
Current Industry
-6.7%
Current Market
177.3%

Be the first to know when ZEAL announces earnings.

ZEAL Return on Assets

Current Company
-53.2%
Current Industry
4.2%

ZEAL Return on Capital Employed

Current Company
-58.34%
Current Industry
4.4%
ZEAL's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ZEAL vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ZEAL$43.02M-$148.70M-$149.73M+6.29%N/A
MCRB$136.66M-$88.83M-$103.14M+43.99%N/A
SIGA$147.41M$92.53M$71.77M+47.26%-93.77%
ALVR$0.00-$188.67M-$191.95MN/AN/A
SGMO$114.16M-$152.78M-$172.33M+37.27%N/A

Zealand Pharma A Earnings & Revenue FAQ

What was ZEAL's earnings growth in the past year?

As of Q3 2022, Zealand Pharma A's earnings has grown year over year. Zealand Pharma A's earnings in the past year totalled -$149.73 million.

If you're new to stock investing, here's how to buy Zealand Pharma A stock.

What was ZEAL's revenue growth in the past year?

As of Q3 2022, Zealand Pharma A's revenue has grown -23.47% year over year. This is 1,152.56 percentage points lower than the US Biotechnology industry revenue growth rate of 1,129.09%. Zealand Pharma A's revenue in the past year totalled $43.02 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.